0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

Estimated Influenza Vaccination Coverage Among Adults and Children—United States, September 1, 2004–January 31, 2005 FREE

JAMA. 2005;293(19):2334-2336. doi:10.1001/jama.293.19.2334.
Text Size: A A A
Published online

ESTIMATED INFLUENZA VACCINATION COVERAGE AMONG ADULTS AND CHILDREN—UNITED STATES, SEPTEMBER 1, 2004–JANUARY 31, 2005

MMWR. 2005;54:304-307

1 figure, 2 tables omitted

In response to the unexpected shortfall in the 2004-05 influenza vaccine supply, CDC recommended in October 2004 that vaccine be reserved for persons in certain priority groups, including persons aged ≥65 years and 6-23 months, persons aged 2-64 years with conditions that increased their risk for influenza complications, residents of chronic-care facilities, close contacts of infants aged <6 months, and health-care workers with direct patient contact.1 In late December 2004, based on declining demand among these groups, two additional groups (i.e., healthy persons aged 50-64 years and household contacts of all persons at high risk) were added to the list of vaccination priority groups.2 To monitor influenza vaccination coverage during the 2004-05 season, the Behavioral Risk Factor Surveillance System (BRFSS), an ongoing, state-based, telephone survey of civilian, noninstitutionalized persons, added new questions to collect information on priority status and the month and year of vaccination for adults and children.3 This report is based on analysis of data collected during February 1-27, 2005, regarding respondent-reported receipt of influenza vaccination during September 1, 2004–January 31, 2005. The results of this analysis indicated that influenza vaccination coverage levels through January 2005 among adults in priority groups nearly reached those in recent years, whereas coverage levels among adults not in priority groups were approximately half of levels in 2003, in part because 9.3% of those unvaccinated persons in nonpriority groups declined vaccination this season. The results further suggested that designation of the priority groups successfully directed the nation’s influenza vaccine supply to those at highest risk. In addition, vaccination coverage among children aged 6-23 months was notable (48.4%), given that 2004-05 was the first year this group was recommended for influenza vaccination.4

In previous years, BRFSS asked adult respondents whether they had been vaccinated against influenza during the preceding 12 months. No influenza vaccination questions were asked regarding children, and the only questions related to high-risk medical conditions referred to diabetes and asthma. To more closely monitor coverage during this shortfall season, influenza vaccination questions were added during November 2004–February 2005 regarding children, priority group status, and month and year of vaccination. For comparison with the 2004-05 season, data from the 2003 National Health Interview Survey (NHIS) were used. Similar to the BRFSS survey question, NHIS routinely asks adult respondents if they received a “flu shot” during the preceding 12 months; NHIS also collects information on occupations and high-risk medical conditions. NHIS was conducted during 2003 and consisted of in-person interviews; the household response rate was 89.2%. For children, the only previous available national data on influenza vaccine coverage were collected in the 2003 National Immunization Survey (NIS), which reported on vaccination coverage during the 2002-03 season for children aged 6-23 months with an overall response rate among eligible households of 62.7%.5

Because BRFSS data collection is ongoing, final response rates for February were not yet available. Preliminary estimates indicate that the median state-level response rate for February was 51.7% (range: 33.4%-69.8%), based on CASRO guidelines. Analysis was based on 26,868 interviews from 50 states and the District of Columbia.

Vaccination Coverage Among Adults

Among adults, influenza vaccination coverage through January of the 2004-05 season was highest among persons aged ≥65 years (62.7%), followed by health-care workers with patient contact (35.7%) and those aged 18-64 years with high-risk conditions (25.5%). In comparison, the 2003 NHIS indicated coverage of 65.6% for persons aged ≥65 years, 40.1% for health-care workers, and 34.2% for adults aged 18-64 years with high-risk conditions. In contrast, influenza vaccination coverage among healthy persons aged 18-64 years who were not health-care workers or contacts of children aged <6 months was lower than in the previous season (8.8% compared with 17.8%) (CDC, unpublished data, 2005). Among the reasons cited by respondents for not receiving vaccination, was “saving vaccine for people who need it more,” cited by 9.3% of those who were not in priority groups and were not vaccinated. This represents approximately 17.5 million doses of vaccine potentially made available to persons in priority groups.

Vaccination uptake was higher in October and November and tapered off during December and January. Among the adults in the priority groups established in October, 2% of the vaccinations through January occurred in September, 40% in October, 32% in November, 17% in December, and 9% in January.

Vaccination Coverage Among Children

Influenza vaccination coverage (≥1 doses) among children aged 6-23 months (48.4%) and among children aged 2-17 years with high-risk conditions (34.8%) was substantially higher than among children not in priority groups (12.3%). Of the vaccinations received through January, 17% occurred in September, 23% in October, 28% in November, 20% in December, and 12% in January. In comparison, the 2003 NIS data indicated that coverage among children aged 6-23 months for the 2002-03 influenza season, before they were recommended for vaccination by the Advisory Committee on Immunization Practices (ACIP), was 7.4%.5

Reported by: GL Euler, DrPH, CB Bridges, MD, CJ Brown, MS, PJ Lu, PhD, J Singleton, MS, Epidemiology and Surveillance Div; S Stokley, MPH, Immunization Svcs Div; SY Chu, PhD, M McCauley, MTSC, Office of the Director, National Immunization Program; MW Link, PhD, AH Mokdad, PhD, L Elam-Evans, PhD, LS Balluz, ScD, WS Garvin, WP Bartoli, GM Town, MS, M Sussman-Walsh, K O’Neill, D Gilbertz, Div of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, CDC.

CDC Editorial Note: During September 1, 2004–January 31, 2005, estimates of influenza vaccination coverage indicate that despite an unexpected and substantial vaccine shortfall, coverage levels among adults in the original influenza vaccine priority groups were similar to historical demand based on the 2003 NHIS,3 thereby suggesting the effectiveness of prioritization. This resulted, in part, from the estimated 17.5 million persons not in priority groups whose primary reported reason for not being vaccinated was to save vaccine for people who needed it more. According to the February 2005 BRFSS, approximately two thirds of the administered vaccine doses through January went to persons in the initial priority groups identified in October whereas, during 2003, only approximately one half of all doses of influenza vaccine were administered to persons in these groups.

The provision of ≥1 doses of influenza vaccination to 48.4% of children aged 6-23 months during this first influenza season following implementation of the ACIP recommendations suggests how quickly physicians and parents can adopt a new disease-prevention guideline.46 Because the Chiron vaccine was not licensed for use in children aged <4 years, the supply of influenza vaccine for children aged 6-23 months was not affected by the shortfall.

For the first time, a nationwide, state-based surveillance system (i.e., BRFSS) was used to assess influenza vaccination coverage by month of vaccination and provided the capability to report at intervals as brief as 1 week. This surveillance system also provided the first national influenza vaccination coverage estimates for children aged 2-17 years with high-risk conditions. Having national and state population-based estimates of vaccination coverage by month and priority status from early in the influenza season afforded policy makers, health-care providers, public health leaders, and the public timely information to make decisions regarding distribution and usage of the limited supply of vaccine.

The findings in this report are subject to at least four limitations. First, BRFSS is a land-line telephone–based survey and excludes those segments of the population without telephones or who use only cellular telephones. Second, data are self-reported and subject to recall bias, particularly for questions that require recall over a longer period; therefore, for certain behaviors, prevalence estimates might be under- or overreported. Third, certain influenza vaccine priority groups were not considered in the survey, including institutionalized adults and adult caretakers of children aged <6 months outside of the home (e.g., child care workers). Finally, these results do not include all of the vaccinations received during the 2004-05 influenza season. However, based on reports of vaccination, estimated 2004-05 coverage appeared to increase by less than one percentage point during February among all the priority and nonpriority groups except those aged 6-23 months, among whom coverage appeared to increase nearly four percentage points, from 48.4% to 52.2%.

Comparability of findings from the BRFSS survey with results of the 2003 NHIS is limited because of differences in the survey designs and timeframes. First, the 2003 NHIS is conducted throughout the entire 2003 calendar year. Thus, the results reflect vaccinations received anytime during the entire 2002-03 influenza season and vaccinations received during parts of both the 2001-02 and 2003-04 seasons. Second, the interviews are conducted in person, rather than by telephone. Analysis of 2005 NHIS data, when they become available, will be helpful to further assess the impact of the 2004-05 vaccine shortfall and to provide comparisons with results from the February 2005 BRFSS survey.

Vaccination patterns during the 2004-05 influenza season have been affected by several factors. Although an unexpected and substantial reduction of vaccine supply occurred at the beginning of the season, prioritization was quickly recommended and followed. The 2004-05 influenza season was less severe than the 2003-04 season and did not peak until mid-February.7 In addition, this was the first full season following the ACIP recommendation to vaccinate all children aged 6-23 months.

Despite the shortfall of inactivated influenza vaccine, the level of coverage achieved among those groups prioritized in 2004-05 appears to be similar to historical coverage. Additional guidelines for prioritization of influenza vaccination in the event of a future influenza vaccine shortfall are in development and should assist with efforts to maximize use of available vaccine.

REFERENCES
CDC.  Interim influenza vaccination recommendations, 2004-05 influenza season.  MMWR. 2004;53:923-924
CDC.  Revised interim guidance for late-season influenza vaccination January 27, 2005. Available at http://www.cdc.gov/flu/protect/pdf/fluvaccine-lateseasonguidance.pdf
CDC.  Estimated influenza vaccination coverage among adults and children—United States, September 1–November 30, 2004.  MMWR. 2004;53:1147-1153
Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep.. 2004;53:1-40
PubMed
CDC.  Childhood influenza-vaccination coverage—United States, 2002-03 influenza season.  MMWR. 2004;53:863-866
Bridges CD, Fukuda K, Uyeki TM, Cox NJ, Singleton JA.CDC.  Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep.. 2002;51:1-31
PubMed
CDC.  Weekly report: influenza summary update: week ending March 5, 2005-week 9. Available at http://www.cdc.gov/flu/weekly.

Figures

Tables

References

CDC.  Interim influenza vaccination recommendations, 2004-05 influenza season.  MMWR. 2004;53:923-924
CDC.  Revised interim guidance for late-season influenza vaccination January 27, 2005. Available at http://www.cdc.gov/flu/protect/pdf/fluvaccine-lateseasonguidance.pdf
CDC.  Estimated influenza vaccination coverage among adults and children—United States, September 1–November 30, 2004.  MMWR. 2004;53:1147-1153
Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep.. 2004;53:1-40
PubMed
CDC.  Childhood influenza-vaccination coverage—United States, 2002-03 influenza season.  MMWR. 2004;53:863-866
Bridges CD, Fukuda K, Uyeki TM, Cox NJ, Singleton JA.CDC.  Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices (ACIP).  MMWR Recomm Rep.. 2002;51:1-31
PubMed
CDC.  Weekly report: influenza summary update: week ending March 5, 2005-week 9. Available at http://www.cdc.gov/flu/weekly.

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Ten years (2004-2014) of influenza surveillance in Northern Italy. Hum Vaccin Immunother Published online Aug 19, 2014.;
B Cell Responses to Influenza Infection and Vaccination. Curr Top Microbiol Immunol Published online Sep 6, 2014.;